XNCR FY 2024 Earnings — Xencor, Inc. Revenue & Financial Results | Market Cap Arena

XNCRXencor, Inc.

$890M

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$110M-36.7% YoY

Gross Profit

$110M100.0% margin

Operating Income

-$178M-161.5% margin

Net Income

-$233M-210.5% margin

EPS (Diluted)

$-3.58

Cash Flow

Operating Cash Flow

-$202M

Free Cash Flow

-$208M

Stock-Based Comp.

$53M

Balance Sheet

Total Assets

$952M

Total Liabilities

$278M

Stockholders' Equity

$678M

Cash & Equivalents

$41M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$110M	$175M	-36.7%
Gross Profit	$110M	$175M	-36.7%
Operating Income	-$178M	-$132M	-34.8%
Net Income	-$233M	-$133M	-74.7%